Title |
ACE Inhibitor and Angiotensin Receptor-II Antagonist Prescribing and Hospital Admissions with Acute Kidney Injury: A Longitudinal Ecological Study
|
---|---|
Published in |
PLOS ONE, November 2013
|
DOI | 10.1371/journal.pone.0078465 |
Pubmed ID | |
Authors |
Laurie A. Tomlinson, Gary A. Abel, Afzal N. Chaudhry, Charles R. Tomson, Ian B. Wilkinson, Martin O. Roland, Rupert A. Payne |
Abstract |
ACE Inhibitors (ACE-I) and Angiotensin-Receptor Antagonists (ARAs) are commonly prescribed but can cause acute kidney injury (AKI) during intercurrent illness. Rates of hospitalization with AKI are increasing. We aimed to determine whether hospital AKI admission rates are associated with increased ACE-I/ARA prescribing. |
X Demographics
The data shown below were collected from the profiles of 40 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 12 | 30% |
United Kingdom | 5 | 13% |
United States | 4 | 10% |
Switzerland | 1 | 3% |
Italy | 1 | 3% |
Saudi Arabia | 1 | 3% |
Ireland | 1 | 3% |
Unknown | 15 | 38% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 32 | 80% |
Scientists | 6 | 15% |
Practitioners (doctors, other healthcare professionals) | 2 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 2% |
Ireland | 1 | 2% |
Egypt | 1 | 2% |
Unknown | 62 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 13 | 20% |
Researcher | 9 | 14% |
Student > Ph. D. Student | 7 | 11% |
Student > Bachelor | 6 | 9% |
Student > Postgraduate | 5 | 8% |
Other | 13 | 20% |
Unknown | 12 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 33 | 51% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 8% |
Nursing and Health Professions | 4 | 6% |
Chemistry | 3 | 5% |
Business, Management and Accounting | 1 | 2% |
Other | 5 | 8% |
Unknown | 14 | 22% |